22.12.2012 Views

ipsas 29—financial instruments: recognition and measurement - IFAC

ipsas 29—financial instruments: recognition and measurement - IFAC

ipsas 29—financial instruments: recognition and measurement - IFAC

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

FINANCIAL INSTRUMENTS: RECOGNITION AND MEASUREMENT<br />

borrowers. In such cases, an entity uses its experienced judgment to estimate the<br />

amount of any impairment loss. Similarly an entity uses its experienced judgment<br />

to adjust observable data for a group of financial assets to reflect current<br />

circumstances (see paragraph AG122). The use of reasonable estimates is an<br />

essential part of the preparation of financial statements <strong>and</strong> does not undermine<br />

their reliability.<br />

Financial Assets Carried at Amortized Cost<br />

72. If there is objective evidence that an impairment loss on loans <strong>and</strong><br />

receivables or held-to-maturity investments carried at amortized cost has<br />

been incurred, the amount of the loss is measured as the difference between<br />

the asset’s carrying amount <strong>and</strong> the present value of estimated future cash<br />

flows (excluding future credit losses that have not been incurred) discounted<br />

at the financial asset’s original effective interest rate (i.e., the effective interest<br />

rate computed at initial <strong>recognition</strong>). The carrying amount of the asset shall<br />

be reduced either directly or through use of an allowance account. The<br />

amount of the loss shall be recognized in surplus or deficit.<br />

73. An entity first assesses whether objective evidence of impairment exists<br />

individually for financial assets that are individually significant, <strong>and</strong> individually<br />

or collectively for financial assets that are not individually significant (see<br />

paragraph 68). If an entity determines that no objective evidence of impairment<br />

exists for an individually assessed financial asset, whether significant or not, it<br />

includes the asset in a group of financial assets with similar credit risk<br />

characteristics <strong>and</strong> collectively assesses them for impairment. Assets that are<br />

individually assessed for impairment <strong>and</strong> for which an impairment loss is or<br />

continues to be recognized are not included in a collective assessment of<br />

impairment.<br />

74. If, in a subsequent period, the amount of the impairment loss decreases <strong>and</strong><br />

the decrease can be related objectively to an event occurring after the<br />

impairment was recognized (such as an improvement in the debtor’s credit<br />

rating), the previously recognized impairment loss shall be reversed either<br />

directly or by adjusting an allowance account. The reversal shall not result in<br />

a carrying amount of the financial asset that exceeds what the amortized cost<br />

would have been had the impairment not been recognized at the date the<br />

impairment is reversed. The amount of the reversal shall be recognized in<br />

surplus or deficit.<br />

Financial Assets Carried at Cost<br />

75. If there is objective evidence that an impairment loss has been incurred on<br />

an unquoted equity instrument that is not carried at fair value because its<br />

fair value cannot be reliably measured, or on a derivative asset that is linked<br />

to <strong>and</strong> must be settled by delivery of such an unquoted equity instrument, the<br />

amount of the impairment loss is measured as the difference between the<br />

IPSAS 29 1054

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!